UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
CASIF holding history
CASI Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CASIF overviewAll 13F holders of CASIFFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −659−100.0% | Sold out | Holders |
| Q4 2025 | 659 | $560 | <0.1% | +645+4,607.1% | Added | Holders |
| Q3 2025 | 14 | $23 | <0.1% | −940−98.5% | Reduced | Holders |
| Q2 2025 | 954 | $1.13K | <0.1% | −2,135−69.1% | Reduced | Holders |
| Q1 2025 | 3,089 | $6.67K | <0.1% | −8,219−72.7% | Reduced | Holders |
| Q4 2024 | 11,308 | $32.0K | <0.1% | −3,373−23.0% | Reduced | Holders |
| Q3 2024 | 14,681 | $90.4K | <0.1% | +3,360+29.7% | Added | Holders |
| Q2 2024 | 11,321 | $62.3K | <0.1% | +11,321 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −1,222−100.0% | Sold out | Holders |
| Q4 2023 | 1,222 | $8.75K | <0.1% | +1,222 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −6,175−100.0% | Sold out | Holders |
| Q1 2023 | 6,175 | $14.3K | <0.1% | +6,175 | New | Holders |